Lancet study: No statistically significant clinical benefits of remdesivir in COVID patients | India News,The Indian Express

Lancet study: No statistically significant clinical benefits of remdesivir in COVID patients | India News,The Indian Express

Lancet study: No statistically significant clinical benefits of remdesivir in COVID patients

Written by Abantika Ghosh | New Delhi | Updated: April 30, 2020 at 6:30 am

In a study in the medical journal The Lancet, Chinese researchers have reported that they could not find any “statistically significant clinical benefits”.